EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Serum Parathyroid Hormone Levels and Femoral Bone Mineral Density in Patients with Chronic Kidney Disease Stage 3

Laura Montaño-Azor, Petra Cantón Guerrero, María Ángeles Jiménez Sánchez, María José Jiménez Moral, Raquel María García-Sáez iD, María Encarnación Rodríguez-Ortiz iD, Mariano Rodríguez iD, Victoria Pendón-Ruiz de Mier iD, Esperanza Romero-Rodríguez

Journal of Clinical Medicine · 14.07.2026 · 15 (14) · 5519

DOI: 10.3390/jcm15145519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.07.2026. Verfasst von Laura Montaño-Azor und 8 weiteren Autor:innen. Beteiligte Einrichtung: Multiprofessional Teaching Unit for Family and Community Care of Córdoba, 14011 Cordoba, Spain. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Health Carlos III, Instituto de Salud Carlos III, European Union NextGenerationEU/PRTR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is associated with early disturbances in mineral metabolism that contribute to bone fragility. Secondary hyperparathyroidism is a key component of chronic kidney disease–mineral and bone disorder (CKD-MBD) and may affect bone even during the early stages of CKD. This study evaluated the association between serum parathyroid hormone (PTH) concentrations and bone mineral density (BMD) in patients with stage 3 CKD.

Methods

A multicenter cross-sectional observational study was conducted in 203 patients with stage 3 CKD. Blood and 24 h urine samples were collected to measure creatinine, calcium, phosphate, magnesium, 25-hydroxyvitamin D, fibroblast growth factor 23 (FGF23), and PTH. Bone mineral density was assessed by dual-energy X-ray absorptiometry (DXA). Associations between serum PTH concentrations and BMD were analyzed.

Results

Elevated serum PTH concentrations were associated with lower femoral BMD and less favorable femoral T-scores, whereas no significant associations were observed at the lumbar spine. Serum PTH concentrations were inversely correlated with femoral BMD and femoral T-scores. Patients with reduced femoral BMD also showed higher FGF23 concentrations and lower renal function, while serum calcium, phosphate, magnesium, and 25-hydroxyvitamin D concentrations did not differ significantly among the groups.

Conclusions

Elevated serum PTH concentrations were associated with reduced femoral BMD in patients with stage 3 CKD, supporting preferential early involvement of cortical bone. Serum PTH may represent an accessible biomarker for the early identification of patients at increased risk of cortical bone loss before conventional biochemical abnormalities become clinically apparent.

Schlagwörter

Stichwörter der Autor:innen

bone mineral densitychronic kidney diseasechronic kidney disease–mineral and bone disorderdual-energy X-ray absorptiometryfibroblast growth factor 23parathyroid hormonesecondary hyperparathyroidism

Autor:innen und Institutionen

  • Multiprofessional Teaching Unit for Family and Community Care of Córdoba, 14011 Cordoba, Spain.
  • Palma del Río Health Center, Andalusian Health Service, 14700 Cordoba, Spain.
  • Córdoba Guadalquivir Health District, Andalusian Health Service, 14011 Cordoba, Spain.
  • Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), 14004 Cordoba, Spain.
  • Nephrology Service, Reina Sofía University Hospital, 14004 Córdoba, Spain.
  • University of Cordoba, 14004 Cordoba, Spain.

ORCID-Profile: Raquel María García-Sáez, María Encarnación Rodríguez-Ortiz, Mariano Rodríguez, Victoria Pendón-Ruiz de Mier

Förderung

  • Institute of Health Carlos III
  • Instituto de Salud Carlos III
  • European Union NextGenerationEU/PRTR

Zitieren

APA

Montaño-Azor, L., Cantón Guerrero, P., Jiménez Sánchez, M. Á., Jiménez Moral, M. J., García-Sáez, R. M., Rodríguez-Ortiz, M. E., Rodríguez, M., Pendón-Ruiz de Mier, V., & Romero-Rodríguez, E. (2026). Association Between Serum Parathyroid Hormone Levels and Femoral Bone Mineral Density in Patients with Chronic Kidney Disease Stage 3. Journal of Clinical Medicine, 15(14), 5519. https://doi.org/10.3390/jcm15145519

Vancouver

Montaño-Azor L, Cantón Guerrero P, Jiménez Sánchez MÁ, Jiménez Moral MJ, García-Sáez RM, Rodríguez-Ortiz ME, et al. Association Between Serum Parathyroid Hormone Levels and Femoral Bone Mineral Density in Patients with Chronic Kidney Disease Stage 3. Journal of Clinical Medicine. 2026;15(14):5519. doi:10.3390/jcm15145519

BibTeX
@article{MontaoAzor2026,
  author = {Montaño-Azor, Laura and Cantón Guerrero, Petra and Jiménez Sánchez, María Ángeles and Jiménez Moral, María José and García-Sáez, Raquel María and Rodríguez-Ortiz, María Encarnación and Rodríguez, Mariano and Pendón-Ruiz de Mier, Victoria and Romero-Rodríguez, Esperanza},
  title = {Association Between Serum Parathyroid Hormone Levels and Femoral Bone Mineral Density in Patients with Chronic Kidney Disease Stage 3},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {5519},
  doi = {10.3390/jcm15145519}
}
Kostenlos starten →